To study the effect of TILAKUSUMADILEPA in skin disease

A Comparative Phase 2 Clinical Study To Evaluate Efficacy Of Tilakusumadilepa And Vipadikahar Lepa In The Management Of Vipadika With Special Rereference To Palmo-Plantar Psoriasis.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/01/039662

Enrollment

Registered

2022-01-21

Start date

Unknown

Completion date

Unknown

Last updated

2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L99- Other disorders of skin and subcutaneous tissue in diseases classified elsewhere

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients with classical signs and symptoms of vipadika - panipadsphutan, vedana Kandu Kharasparshata Strava Patients of Age group - 18 - 60 years of Age. Patients willing to participate in the study , who give written consent

Exclusion criteria

Exclusion criteria: Patients below 18 & above 60 years of age. Patients with other uncontrolled systemic disorders like DM/ HTN/Cardiac disorders/leprosy/Tuberculosis/Malignancy will be excluded. Patients with other skin diseases Like Ringworm, scabies, Eczema etc.

Design outcomes

Primary

Measure	Time frame
REDUCTION IN SIGN AND SYMPTOMS OF VIPADIKATimepoint: 30 days	—

Secondary

Measure	Time frame
COST EFFECTIVE TREATMENTTimepoint: 30 DAYS	—

Countries

India

Contacts

Public ContactVd Ekanath G Kulkarni

AYURVED SEVA SANGHA, AYURVED MAHAVIDYALAYA

ekulkarni6@gmail.com9699085576

Outcome results